
AVRO
Healthcare · Biotechnology · $5.2M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2024
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 9, 2024 | After the close | -0.36 | -0.15 | +58.3% |
| Mar 14, 2024 | After the close | -0.34 | -0.20 | +41.2% |
| Nov 9, 2023 | After the close | -0.28 | -0.44 | -57.1% |
| Aug 10, 2023 | After the close | -0.07 | -0.37 | -428.6% |
| May 11, 2023 | Before the open | -0.55 | -0.57 | -3.6% |
| Mar 23, 2023 | Before the open | -0.49 | -0.57 | -16.3% |
| Nov 8, 2022 | Before the open | -0.55 | -0.52 | +5.5% |
| Aug 9, 2022 | Before the open | -0.57 | -0.64 | -12.3% |
| May 10, 2022 | Before the open | -0.59 | -0.68 | -15.3% |
| Mar 17, 2022 | Before the open | -0.74 | -0.65 | +12.2% |
| Nov 4, 2021 | Before the open | -0.76 | -0.75 | +1.3% |
| Aug 5, 2021 | Before the open | -0.67 | -0.74 | -10.4% |
| May 13, 2021 | Before the open | -0.77 |
AVROBIO, Inc., a clinical-stage gene therapy company, develops hematopoietic stem cell gene therapies to treat rare diseases in the United States. Its gene therapies employ hematopoietic stem cells that are harvested from the patient and then modified with a lentiviral vector to insert the equivalent of a functional copy of the gene that is mutated in the target disease. The company's pipeline includes AVR-RD-02,…
| -0.65 |
| +15.6% |
| Mar 18, 2021 | Before the open | -0.90 | -0.73 | +18.9% |
| Nov 5, 2020 | Before the open | -0.80 | -1.01 | -26.3% |
| Aug 6, 2020 | Before the open | -0.76 | -0.80 | -5.3% |
| May 7, 2020 | Before the open | -0.67 | -0.77 | -14.9% |
| Mar 16, 2020 | Before the open | -0.59 | -0.72 | -22.0% |
| Nov 7, 2019 | Before the open | -0.59 | -0.57 | +3.4% |
| Aug 8, 2019 | Before the open | -0.76 | -0.67 | +11.8% |
| May 13, 2019 | Before the open | -0.72 | -0.72 | 0.0% |
| Mar 25, 2019 | Before the open | -0.57 | -0.67 | -17.5% |
| Nov 13, 2018 | Before the open | -0.91 | -0.49 | +46.2% |
| Aug 9, 2018 | Before the open | -0.47 | -2.98 | -534.0% |
| Jun 21, 2018 | After the close | 0.00 | -0.50 | — |
| Mar 21, 2018 | Time not confirmed | — | 0.02 | — |